In other words, we thought that the high predicted Framingham CHD risk was independently associated with detectable hs-cTnT in all levels of eGFR, while reduced level of eGFR as an independent factor was added on high predicted Framingham CHD risk in association with detectable hs-cTnT in moderate-to-severe reduced renal function. The gene discussed is TNNT2; the disease is coronary artery disorder.